Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 26:15:1439598.
doi: 10.3389/fneur.2024.1439598. eCollection 2024.

Prediction of TERT mutation status in gliomas using conventional MRI radiogenomic features

Affiliations

Prediction of TERT mutation status in gliomas using conventional MRI radiogenomic features

Chuyun Tang et al. Front Neurol. .

Abstract

Objective: Telomerase reverse transcriptase (TERT) promoter mutation status in gliomas is a key determinant of treatment strategy and prognosis. This study aimed to analyze the radiogenomic features and construct radiogenomic models utilizing medical imaging techniques to predict the TERT promoter mutation status in gliomas.

Methods: This was a retrospective study of 304 patients with gliomas. T1-weighted contrast-enhanced, apparent diffusion coefficient, and diffusion-weighted imaging MRI sequences were used for radiomic feature extraction. A total of 3,948 features were extracted from MRI images using the FAE software. These included 14 shape features, 18 histogram features, 24 gray level run length matrix, 14 gray level dependence matrix, 16 gray level run length matrix, 16 gray level size zone matrix (GLSZM), 5 neighboring gray tone difference matrix, and 744 wavelet transforms. The dataset was randomly divided into training and testing sets in a ratio of 7:3. Three feature selection methods and six classification algorithms were used to model the selected features. Predictive performance was evaluated using receiver operating characteristic curve analysis.

Results: Among the evaluated classification algorithms, the combination model of recursive feature elimination (RFE) with linear regression (LR) using six features showed the best diagnostic performance (area under the curve: 0.733, 0.562, and 0.633 in the training, validation, and testing sets, respectively). The next best-performing models were naive Bayes, linear discriminant analysis, autoencoder, and support vector machine. Regarding the three feature selection algorithms, RFE showed the most consistent performance, followed by relief and ANOVA. T1-enhanced entropy and GLSZM derived from T1-enhanced images were identified as the most critical radiomics features for distinguishing TERT promoter mutation status.

Conclusion: The LR and LRLasso models, mainly based on T1-enhanced entropy and GLSZM, showed good predictive ability for TERT promoter mutations in gliomas using radiomics models.

Keywords: TERT promoter mutation; glioma; machine learning; magnetic resonance imaging; radiomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The patient selection flow chart.
Figure 2
Figure 2
Procedure for image processing, extraction of radiomic features, and machine learning.
Figure 3
Figure 3
Performance of the model derived from recursive feature elimination (RFE) combined with Linear Regression (LR): (A) ROC curves for the validation set, training set, and test set; (B) Following the “one standard error” principle, the maximum number of features in the model was reduced to 6; (C) Ranking of omics feature contributions from the best model derived from the combination of RFE and LR.
Figure 4
Figure 4
Performance of the model derived from recursive feature elimination (RFE) combined with logistic regression via the least absolute shrinkage and selection operator (LRLasso): (A) ROC curves for the validation set, training set, and test set; (B) Following the “one standard error” principle, the maximum number of features in the model was reduced to 6; (C) Ranking of omics feature contributions from the best model derived from the combination of RFE and LRLasso.
Figure 5
Figure 5
Performance of the model derived from relief combined with auto encoder (AE): (A) ROC curves for the validation set, training set, and test set; (B) Following the “one standard error” principle, the maximum number of features in the model was reduced to 12; (C) Ranking of omics feature contributions from the best model derived from the combination of relief and AE.
Figure 6
Figure 6
Performance of the model derived from relief combined with Naive Bayes (NB): (A) ROC curves for the validation set, training set, and test set; (B) Following the “one standard error” principle, the maximum number of features in the model was reduced to 12; (C) Ranking of omics feature contributions from the best model derived from the combination of relief and NB.
Figure 7
Figure 7
The performance evaluation of models when 3 feature selection methods (including ANOVA, RFE and relief) were integrated with 6 algorithms. (A) ANOVA. (B) RFE. (C) Relief.
Figure 8
Figure 8
Comparison of performance when pairing LR, LRLasso, NB, AE, LDA, and SVM classification algorithms with three feature selection methods. (A) LR. (B) LRLasso. (C) NB. (D) AE. (E) LDA. (F) SVM.

Similar articles

References

    1. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre J-Y. Primary brain tumours in adults. Lancet. (2012) 379:1984–96. doi: 10.1016/S0140-6736(11)61346-9 - DOI - PubMed
    1. Lansdorp PM. Telomeres, aging, and cancer: the big picture. Blood. (2022) 139:813–21. doi: 10.1182/blood.2021014299, PMID: - DOI - PMC - PubMed
    1. Bonnell E, Pasquier E, Wellinger RJ. Telomere replication: solving multiple end replication problems. Front Cell Dev Biol. (2021) 9:668171. doi: 10.3389/fcell.2021.668171, PMID: - DOI - PMC - PubMed
    1. Lansdorp PM. Major cutbacks at chromosome ends. Trends Biochem Sci. (2005) 30:388–95. doi: 10.1016/j.tibs.2005.05.004 - DOI - PubMed
    1. Minami N, Hong D, Stevers N, Barger CJ, Radoul M, Hong C, et al. . Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma. Neuro Oncol. (2022) 24:1898–910. doi: 10.1093/neuonc/noac112, PMID: - DOI - PMC - PubMed

LinkOut - more resources